IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OPTN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

OptiNose Inc. stock price ended at $1.19 on Monday, after losing 2.46%.
(Updated on Apr 15, 2024)

Sell candidate since Apr 11, 2024 Loss -4.03% PDF

The OptiNose Inc. stock price fell by -2.46% on the last day (Monday, 15th Apr 2024) from $1.22 to $1.19. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.17% from a day low at $1.16 to a day high of $1.22. The price has fallen in 8 of the last 10 days and is down by -17.36% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -293 thousand shares and in total, 497 thousand shares were bought and sold for approximately $591.06 thousand.

Given the current short-term trend, the stock is expected to rise 9.02% during the next 3 months and, with a 90% probability hold a price between $1.30 and $2.16 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

OPTN Signals & Forecast

There are few to no technical positive signals at the moment. The OptiNose Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.25 and $1.60. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 18, 2024, and so far it has fallen -38.50%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for OptiNose Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0600 between high and low, or 5.17%. For the last week the stock has had daily average volatility of 6.28%.

OptiNose Inc. is oversold on RSI14 (8). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OPTN) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect OptiNose Inc. to open at $1.19, and during the day (based on 14 day Average True Range), to move between $1.09 and $1.29, which gives a possible trading interval of +/-$0.0985 (+/-8.27%) up or down from last closing price. If OptiNose Inc. takes out the full calculated possible swing range there will be an estimated 16.55% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.22, some $0.0300 (2.52%) from the current price of $1.19, our system finds the risk reward not very attractive.

Is OptiNose Inc. stock A Buy?

The OptiNose Inc. stock holds several negative signals and despite the positive trend, we believe OptiNose Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.989 Sell Candidate Unchanged

Predicted Opening Price for OptiNose Inc. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$1.19 ( 0%) $1.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OPTN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.25 5.04 %
R2 1.23 3.12 %
R1 1.21 1.93 %
Current price: 1.19
Support S1 1.17 -1.93 %
S2 1.15 -3.12 %
S3 1.13 -5.04 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.47 23.53 %
R2 1.46 22.69 %
R1 1.22 2.52 %
Current price 1.19
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for OptiNose Inc. Stock and on which exchange is it traded?
The symbol for OptiNose Inc. is OPTN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell OptiNose Inc. Stock?
The OptiNose Inc. stock holds several negative signals and despite the positive trend, we believe OptiNose Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy OptiNose Inc. Stock?
OptiNose Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy OptiNose Inc. Stock.

What's the current price of OptiNose Inc. Stock?
As of the end of day on the 2024-04-15, the price of an OptiNose Inc. (OPTN) share was $1.19.

What is the 52-week high and low for OptiNose Inc. Stock?
The 52-week high for OptiNose Inc. Stock is $2.10 and the 52-week low is $0.90.

What is the market capitalization of OptiNose Inc. Stock?
As of the 2024-04-15, the market capitalization of OptiNose Inc. is 134.056M.

When is the next earnings date for OptiNose Inc.?
The upcoming earnings date for OptiNose Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About OptiNose Inc.

OptiNose. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb c... OPTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT